Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,897 | 5,720 | 6,190 | 5,932 | 6,762 |
| Receivables | 67 | 50 | 17 | 553 | 45 |
| TOTAL | $58,222 | $5,987 | $6,266 | $6,501 | $6,839 |
| Non-Current Assets | |||||
| PPE Net | 177 | 118 | 12 | 30 | 48 |
| TOTAL | $177 | $118 | $12 | $30 | $48 |
| Total Assets | $58,399 | $6,105 | $6,278 | $6,531 | $6,887 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 374 | 408 | 150 | 801 | 800 |
| Accrued Expenses | 15 | 42 | 15 | 10 | 0 |
| TOTAL | $462 | $529 | $179 | $846 | $854 |
| Non-Current Liabilities | |||||
| TOTAL | $110 | $40 | $0 | $0 | $0 |
| Total Liabilities | $572 | $568 | $179 | $846 | $854 |
| Shareholders' Equity | |||||
| Common Shares | 89,020 | 35,423 | 35,047 | 35,047 | 35,047 |
| Retained earnings | -34,299 | -34,349 | -33,576 | -33,805 | -33,231 |
| Other shareholders' equity | 3,107 | 4,462 | 4,628 | 4,444 | 4,217 |
| TOTAL | $57,827 | $5,536 | $6,099 | $5,685 | $6,033 |
| Total Liabilities And Equity | $58,399 | $6,105 | $6,278 | $6,531 | $6,887 |